Avalo Therapeutics (AVTX) Revenue (2016 - 2025)
Avalo Therapeutics posted quarterly Revenue of $59000.0 for Q4 2025, down 69.27% year-on-year from $192000.0 in Q4 2024, and down 69.27% on a QoQ basis from $192000.0 in Q4 2024.
Avalo Therapeutics (AVTX) has 10 years of Revenue data on file, last reported at $59000.0 in Q4 2025.
- For the quarter ending Q4 2025, Revenue fell 69.27% year-over-year to $59000.0; the trailing twelve-month figure through Dec 2025 stood at $500000.0 (up 13.38% YoY), and the FY2025 full-year result was $59000.0, down 86.62% from the prior year.
- Revenue for Q4 2025 stood at $59000.0, down from $192000.0 in the prior quarter.
- Across five years, Revenue topped out at $14.9 million in Q3 2022 and bottomed at $59000.0 in Q4 2025.
- The 5-year median for Revenue is $571000.0 (2023), against an average of $1.7 million.
- The widest annual swing landed in 2022, when Revenue surged 1007.33%; it then tumbled 98.42% in 2023.
- A 5-year view of Revenue shows it stood at $219000.0 in 2021, then soared by 309.13% to $896000.0 in 2022, then tumbled by 36.27% to $571000.0 in 2023, then sank by 66.37% to $192000.0 in 2024, then slumped by 69.27% to $59000.0 in 2025.
- The last three Revenue figures came in at $59000.0 (Q4 2025), $192000.0 (Q4 2024), and $249000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59,000.00 |
| Dec 31, 2024 | 192,000.00 |
| Sep 30, 2024 | 249,000.00 |
| Dec 31, 2023 | 571,000.00 |
| Sep 30, 2023 | 236,000.00 |
| Jun 30, 2023 | 643,000.00 |
| Mar 31, 2023 | 475,000.00 |
| Dec 31, 2022 | 896,000.00 |
| Sep 30, 2022 | 14.95 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | 219,000.00 |
| Sep 30, 2021 | 1.35 Mn |
| Jun 30, 2021 | 3.36 Mn |
| Mar 31, 2021 | 473,000.00 |
| Dec 31, 2020 | 1.50 Mn |
| Sep 30, 2020 | 1.11 Mn |
| Jun 30, 2020 | 1.34 Mn |
| Mar 31, 2020 | 2.75 Mn |
| Dec 31, 2019 | 580,808.00 |
| Sep 30, 2019 | 2.20 Mn |
| Jun 30, 2019 | 1.39 Mn |
| Mar 31, 2019 | 2.58 Mn |
| Dec 31, 2018 | -6.31 Mn |
| Sep 30, 2018 | 4.07 Mn |
| Jun 30, 2018 | 4.79 Mn |
| Mar 31, 2018 | 4.48 Mn |
| Dec 31, 2017 | 1.91 Mn |
| Sep 30, 2017 | 25.04 Mn |
| Jun 30, 2017 | 157,800.00 |
| Mar 31, 2017 | 384,206.00 |
| Dec 31, 2016 | 182,000.00 |
| Sep 30, 2016 | 321,497.00 |
| Jun 30, 2016 | 650,488.00 |